Global Phage Therapy Market Growth (Status and Outlook) 2025-2031

April 2025 | 157 pages | ID: G25C687CCF5DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global High Pressure Processing (HPP) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

High-Pressure Processing (HPP) is a cutting-edge USDA–approved all natural process that utilizes intense water pressure to protect against harmful bacteria without affecting a food product’s taste, texture, appearance or nutritional value. Products are packaged, sealed and then placed in a cylinder-shaped pressure chamber where it is surrounded by water. Up to 87,000 pounds of water pressure—roughly equal to five to six times the pressure found at the bottom of the deepest ocean—are exerted per square inch, protecting against harmful bacteria and sealing in freshness and flavor naturally, with no preservatives needed. HPP is one of the latest technologies that utilize non-heat methods to preserve food. It has been studied by scientists for more than a hundred years, but only within the past 20 years have companies started applying HPP commercially. In this report, we study the market size of food, which use high pressure processing. Some company, which offer High Pressure Processing (HPP) to the food manufacturing industry, is not covered in our report.

In the United States, key players of high pressure processing (HPP) include Hormel Food, Calavo Growers, Cargill, Wholly Guacamole, etc. Top five manufacturers hold a share over 35%. In terms of product, juices and beverages is the largest segment, with a share over 35%. And in terms of application, the largest application is supermarket, with a share over 60%.

LP Information, Inc. (LPI) ' newest research report, the “High Pressure Processing (HPP) Industry Forecast” looks at past sales and reviews total world High Pressure Processing (HPP) sales in 2024, providing a comprehensive analysis by region and market sector of projected High Pressure Processing (HPP) sales for 2025 through 2031. With High Pressure Processing (HPP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Pressure Processing (HPP) industry.

This Insight Report provides a comprehensive analysis of the global High Pressure Processing (HPP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High Pressure Processing (HPP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Pressure Processing (HPP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Pressure Processing (HPP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Pressure Processing (HPP).

This report presents a comprehensive overview, market shares, and growth opportunities of High Pressure Processing (HPP) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Meat and Poultry Products
• Juices and Beverages
• Fruit and Vegetable
• Seafood Products
• Others

Segmentation by Application:

• Supermarket
• Direct Store
• Online

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Hormel Food
• Calavo Growers
• Cargill
• Wholly Guacamole
• Good Foods
• Perdue Farms
• Suja Life
• Evolution Fresh
• Clearwater Seafoods
• Motivatit

Key Questions Addressed in this Report

What is the 10-year outlook for the global High Pressure Processing (HPP) market?

What factors are driving High Pressure Processing (HPP) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do High Pressure Processing (HPP) market opportunities vary by end market size?

How does High Pressure Processing (HPP) break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Phage Therapy Market Size (2020-2031)
  2.1.2 Phage Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Phage Therapy by Country/Region (2020, 2024 & 2031)
2.2 Phage Therapy Segment by Type
  2.2.1 DsDNA Bacteriophage
  2.2.2 SsDNA Bacteriophage
  2.2.3 SsRNA Bacteriophage
  2.2.4 Others
2.3 Phage Therapy Market Size by Type
  2.3.1 Phage Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Phage Therapy Market Size Market Share by Type (2020-2025)
2.4 Phage Therapy Segment by Application
  2.4.1 Animal Health
  2.4.2 Aquaculture
  2.4.3 Agriculture
  2.4.4 Food Industry
  2.4.5 Human Health
  2.4.6 Others
2.5 Phage Therapy Market Size by Application
  2.5.1 Phage Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Phage Therapy Market Size Market Share by Application (2020-2025)

3 PHAGE THERAPY MARKET SIZE BY PLAYER

3.1 Phage Therapy Market Size Market Share by Player
  3.1.1 Global Phage Therapy Revenue by Player (2020-2025)
  3.1.2 Global Phage Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHAGE THERAPY BY REGION

4.1 Phage Therapy Market Size by Region (2020-2025)
4.2 Global Phage Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Phage Therapy Market Size Growth (2020-2025)
4.4 APAC Phage Therapy Market Size Growth (2020-2025)
4.5 Europe Phage Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Phage Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Phage Therapy Market Size by Country (2020-2025)
5.2 Americas Phage Therapy Market Size by Type (2020-2025)
5.3 Americas Phage Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Phage Therapy Market Size by Region (2020-2025)
6.2 APAC Phage Therapy Market Size by Type (2020-2025)
6.3 APAC Phage Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Phage Therapy Market Size by Country (2020-2025)
7.2 Europe Phage Therapy Market Size by Type (2020-2025)
7.3 Europe Phage Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Phage Therapy by Region (2020-2025)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHAGE THERAPY MARKET FORECAST

10.1 Global Phage Therapy Forecast by Region (2026-2031)
  10.1.1 Global Phage Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Phage Therapy Forecast
  10.1.3 APAC Phage Therapy Forecast
  10.1.4 Europe Phage Therapy Forecast
  10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Phage Therapy Forecast
  10.2.2 Canada Market Phage Therapy Forecast
  10.2.3 Mexico Market Phage Therapy Forecast
  10.2.4 Brazil Market Phage Therapy Forecast
10.3 APAC Phage Therapy Forecast by Region (2026-2031)
  10.3.1 China Phage Therapy Market Forecast
  10.3.2 Japan Market Phage Therapy Forecast
  10.3.3 Korea Market Phage Therapy Forecast
  10.3.4 Southeast Asia Market Phage Therapy Forecast
  10.3.5 India Market Phage Therapy Forecast
  10.3.6 Australia Market Phage Therapy Forecast
10.4 Europe Phage Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Phage Therapy Forecast
  10.4.2 France Market Phage Therapy Forecast
  10.4.3 UK Market Phage Therapy Forecast
  10.4.4 Italy Market Phage Therapy Forecast
  10.4.5 Russia Market Phage Therapy Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Phage Therapy Forecast
  10.5.2 South Africa Market Phage Therapy Forecast
  10.5.3 Israel Market Phage Therapy Forecast
  10.5.4 Turkey Market Phage Therapy Forecast
10.6 Global Phage Therapy Forecast by Type (2026-2031)
10.7 Global Phage Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Phage Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 NPO Microgen
  11.1.1 NPO Microgen Company Information
  11.1.2 NPO Microgen Phage Therapy Product Offered
  11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 NPO Microgen Main Business Overview
  11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
  11.2.1 Proteon Pharmaceuticals Company Information
  11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
  11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Proteon Pharmaceuticals Main Business Overview
  11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
  11.3.1 Phagelux Company Information
  11.3.2 Phagelux Phage Therapy Product Offered
  11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Phagelux Main Business Overview
  11.3.5 Phagelux Latest Developments
11.4 Intralytix
  11.4.1 Intralytix Company Information
  11.4.2 Intralytix Phage Therapy Product Offered
  11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Intralytix Main Business Overview
  11.4.5 Intralytix Latest Developments
11.5 Micreos
  11.5.1 Micreos Company Information
  11.5.2 Micreos Phage Therapy Product Offered
  11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Micreos Main Business Overview
  11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
  11.6.1 Eliava BioPreparations Company Information
  11.6.2 Eliava BioPreparations Phage Therapy Product Offered
  11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Eliava BioPreparations Main Business Overview
  11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
  11.7.1 Locus Biosciences,Inc Company Information
  11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
  11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Locus Biosciences,Inc Main Business Overview
  11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
  11.8.1 Pharmex Group,LLC Company Information
  11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
  11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Pharmex Group,LLC Main Business Overview
  11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
  11.9.1 Pherecydes Pharma Company Information
  11.9.2 Pherecydes Pharma Phage Therapy Product Offered
  11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pherecydes Pharma Main Business Overview
  11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
  11.10.1 APS Biocontrol Ltd. (APS) Company Information
  11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
  11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
  11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
  11.11.1 Qingdao Phagepharm Bio-tech Company Information
  11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
  11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
  11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
  11.12.1 Fixed-Phage Limited Company Information
  11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
  11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Fixed-Phage Limited Main Business Overview
  11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
  11.13.1 Zeptometrix Company Information
  11.13.2 Zeptometrix Phage Therapy Product Offered
  11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Zeptometrix Main Business Overview
  11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
  11.14.1 Phage International, Inc. Company Information
  11.14.2 Phage International, Inc. Phage Therapy Product Offered
  11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Phage International, Inc. Main Business Overview
  11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
  11.15.1 MicroMir Company Information
  11.15.2 MicroMir Phage Therapy Product Offered
  11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 MicroMir Main Business Overview
  11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
  11.16.1 iNtODEWORLD, Inc. Company Information
  11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
  11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 iNtODEWORLD, Inc. Main Business Overview
  11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
  11.17.1 NEXTBIOTICS Company Information
  11.17.2 NEXTBIOTICS Phage Therapy Product Offered
  11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 NEXTBIOTICS Main Business Overview
  11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
  11.18.1 Armata Pharmaceuticals, Inc. Company Information
  11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
  11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
  11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
  11.19.1 Innophage Company Information
  11.19.2 Innophage Phage Therapy Product Offered
  11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Innophage Main Business Overview
  11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
  11.20.1 Adaptive Phage Therapeutics Company Information
  11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
  11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Adaptive Phage Therapeutics Main Business Overview
  11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
  11.21.1 TechnoPhage Company Information
  11.21.2 TechnoPhage Phage Therapy Product Offered
  11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 TechnoPhage Main Business Overview
  11.21.5 TechnoPhage Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Phage Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Phage Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DsDNA Bacteriophage
Table 4. Major Players of SsDNA Bacteriophage
Table 5. Major Players of SsRNA Bacteriophage
Table 6. Major Players of Others
Table 7. Phage Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Phage Therapy Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Phage Therapy Market Size Market Share by Type (2020-2025)
Table 10. Phage Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Phage Therapy Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Phage Therapy Market Size Market Share by Application (2020-2025)
Table 13. Global Phage Therapy Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Phage Therapy Revenue Market Share by Player (2020-2025)
Table 15. Phage Therapy Key Players Head office and Products Offered
Table 16. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Phage Therapy Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Phage Therapy Market Size Market Share by Region (2020-2025)
Table 21. Global Phage Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Phage Therapy Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Phage Therapy Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Phage Therapy Market Size Market Share by Country (2020-2025)
Table 25. Americas Phage Therapy Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Phage Therapy Market Size Market Share by Type (2020-2025)
Table 27. Americas Phage Therapy Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Phage Therapy Market Size Market Share by Application (2020-2025)
Table 29. APAC Phage Therapy Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Phage Therapy Market Size Market Share by Region (2020-2025)
Table 31. APAC Phage Therapy Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Phage Therapy Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Phage Therapy Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Phage Therapy Market Size Market Share by Country (2020-2025)
Table 35. Europe Phage Therapy Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Phage Therapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Phage Therapy Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Phage Therapy Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Phage Therapy Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Phage Therapy
Table 41. Key Market Challenges & Risks of Phage Therapy
Table 42. Key Industry Trends of Phage Therapy
Table 43. Global Phage Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Phage Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Phage Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Phage Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 48. NPO Microgen Phage Therapy Product Offered
Table 49. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. NPO Microgen Main Business
Table 51. NPO Microgen Latest Developments
Table 52. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 53. Proteon Pharmaceuticals Phage Therapy Product Offered
Table 54. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Proteon Pharmaceuticals Main Business
Table 56. Proteon Pharmaceuticals Latest Developments
Table 57. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 58. Phagelux Phage Therapy Product Offered
Table 59. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Phagelux Main Business
Table 61. Phagelux Latest Developments
Table 62. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 63. Intralytix Phage Therapy Product Offered
Table 64. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Intralytix Main Business
Table 66. Intralytix Latest Developments
Table 67. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 68. Micreos Phage Therapy Product Offered
Table 69. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Micreos Main Business
Table 71. Micreos Latest Developments
Table 72. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 73. Eliava BioPreparations Phage Therapy Product Offered
Table 74. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Eliava BioPreparations Main Business
Table 76. Eliava BioPreparations Latest Developments
Table 77. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 78. Locus Biosciences,Inc Phage Therapy Product Offered
Table 79. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Locus Biosciences,Inc Main Business
Table 81. Locus Biosciences,Inc Latest Developments
Table 82. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 83. Pharmex Group,LLC Phage Therapy Product Offered
Table 84. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Pharmex Group,LLC Main Business
Table 86. Pharmex Group,LLC Latest Developments
Table 87. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 88. Pherecydes Pharma Phage Therapy Product Offered
Table 89. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Pherecydes Pharma Main Business
Table 91. Pherecydes Pharma Latest Developments
Table 92. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 93. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
Table 94. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. APS Biocontrol Ltd. (APS) Main Business
Table 96. APS Biocontrol Ltd. (APS) Latest Developments
Table 97. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 98. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
Table 99. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Qingdao Phagepharm Bio-tech Main Business
Table 101. Qingdao Phagepharm Bio-tech Latest Developments
Table 102.Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 103.Fixed-Phage Limited Phage Therapy Product Offered
Table 104.Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105.Fixed-Phage Limited Main Business
Table 106.Fixed-Phage Limited Latest Developments
Table 107. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 108. Zeptometrix Phage Therapy Product Offered
Table 109. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Zeptometrix Main Business
Table 111. Zeptometrix Latest Developments
Table 112. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 113. Phage International, Inc. Phage Therapy Product Offered
Table 114. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Phage International, Inc. Main Business
Table 116. Phage International, Inc. Latest Developments
Table 117. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 118. MicroMir Phage Therapy Product Offered
Table 119. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. MicroMir Main Business
Table 121. MicroMir Latest Developments
Table 122. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 123. iNtODEWORLD, Inc. Phage Therapy Product Offered
Table 124. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. iNtODEWORLD, Inc. Main Business
Table 126. iNtODEWORLD, Inc. Latest Developments
Table 127. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 128. NEXTBIOTICS Phage Therapy Product Offered
Table 129. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. NEXTBIOTICS Main Business
Table 131. NEXTBIOTICS Latest Developments
Table 132. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 133. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
Table 134. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Armata Pharmaceuticals, Inc. Main Business
Table 136. Armata Pharmaceuticals, Inc. Latest Developments
Table 137. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 138. Innophage Phage Therapy Product Offered
Table 139. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140. Innophage Main Business
Table 141. Innophage Latest Developments
Table 142. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 143. Adaptive Phage Therapeutics Phage Therapy Product Offered
Table 144. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Adaptive Phage Therapeutics Main Business
Table 146. Adaptive Phage Therapeutics Latest Developments
Table 147. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 148. TechnoPhage Phage Therapy Product Offered
Table 149. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 150. TechnoPhage Main Business
Table 151. TechnoPhage Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Phage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phage Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Phage Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Phage Therapy Sales Market Share by Country/Region (2024)
Figure 8. Phage Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Phage Therapy Market Size Market Share by Type in 2024
Figure 10. Phage Therapy in Animal Health
Figure 11. Global Phage Therapy Market: Animal Health (2020-2025) & ($ millions)
Figure 12. Phage Therapy in Aquaculture
Figure 13. Global Phage Therapy Market: Aquaculture (2020-2025) & ($ millions)
Figure 14. Phage Therapy in Agriculture
Figure 15. Global Phage Therapy Market: Agriculture (2020-2025) & ($ millions)
Figure 16. Phage Therapy in Food Industry
Figure 17. Global Phage Therapy Market: Food Industry (2020-2025) & ($ millions)
Figure 18. Phage Therapy in Human Health
Figure 19. Global Phage Therapy Market: Human Health (2020-2025) & ($ millions)
Figure 20. Phage Therapy in Others
Figure 21. Global Phage Therapy Market: Others (2020-2025) & ($ millions)
Figure 22. Global Phage Therapy Market Size Market Share by Application in 2024
Figure 23. Global Phage Therapy Revenue Market Share by Player in 2024
Figure 24. Global Phage Therapy Market Size Market Share by Region (2020-2025)
Figure 25. Americas Phage Therapy Market Size 2020-2025 ($ millions)
Figure 26. APAC Phage Therapy Market Size 2020-2025 ($ millions)
Figure 27. Europe Phage Therapy Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Phage Therapy Market Size 2020-2025 ($ millions)
Figure 29. Americas Phage Therapy Value Market Share by Country in 2024
Figure 30. United States Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Phage Therapy Market Size Market Share by Region in 2024
Figure 35. APAC Phage Therapy Market Size Market Share by Type (2020-2025)
Figure 36. APAC Phage Therapy Market Size Market Share by Application (2020-2025)
Figure 37. China Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. India Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Phage Therapy Market Size Market Share by Country in 2024
Figure 44. Europe Phage Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Europe Phage Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Germany Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. France Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Phage Therapy Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Phage Therapy Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Phage Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Phage Therapy Market Size 2026-2031 ($ millions)
Figure 60. APAC Phage Therapy Market Size 2026-2031 ($ millions)
Figure 61. Europe Phage Therapy Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Phage Therapy Market Size 2026-2031 ($ millions)
Figure 63. United States Phage Therapy Market Size 2026-2031 ($ millions)
Figure 64. Canada Phage Therapy Market Size 2026-2031 ($ millions)
Figure 65. Mexico Phage Therapy Market Size 2026-2031 ($ millions)
Figure 66. Brazil Phage Therapy Market Size 2026-2031 ($ millions)
Figure 67. China Phage Therapy Market Size 2026-2031 ($ millions)
Figure 68. Japan Phage Therapy Market Size 2026-2031 ($ millions)
Figure 69. Korea Phage Therapy Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Phage Therapy Market Size 2026-2031 ($ millions)
Figure 71. India Phage Therapy Market Size 2026-2031 ($ millions)
Figure 72. Australia Phage Therapy Market Size 2026-2031 ($ millions)
Figure 73. Germany Phage Therapy Market Size 2026-2031 ($ millions)
Figure 74. France Phage Therapy Market Size 2026-2031 ($ millions)
Figure 75. UK Phage Therapy Market Size 2026-2031 ($ millions)
Figure 76. Italy Phage Therapy Market Size 2026-2031 ($ millions)
Figure 77. Russia Phage Therapy Market Size 2026-2031 ($ millions)
Figure 78. Egypt Phage Therapy Market Size 2026-2031 ($ millions)
Figure 79. South Africa Phage Therapy Market Size 2026-2031 ($ millions)
Figure 80. Israel Phage Therapy Market Size 2026-2031 ($ millions)
Figure 81. Turkey Phage Therapy Market Size 2026-2031 ($ millions)
Figure 82. Global Phage Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Phage Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Phage Therapy Market Size 2026-2031 ($ millions)